CIRO+ (Center of expertise for chronic organ failure) and Biomax Informatics announce milestone medical and economic benefits resulting from their ongoing cooperation to deliver the most comprehensive, fully digital system for managed care in chronic lung failure. Business analysis revealed that CIRO+ doubled the number of patients treated at CIRO+ since 2006 while costs during the period went up by only 25%, thus realizing approximately 30% efficiency gain per patient. At the same time, patient outcomes were improved by 50%.
Professor Dr. Emiel Wouters, Chairman of the CIRO+ Board of Directors, links these successes to their ongoing collaboration with Biomax, which began five years ago. “Implementing our ambitious, multidisciplinary approach only became possible through the collaboration with Biomax. The Biomax BioXM system has been in routine use at CIRO+ clinics 24/7 for the past two years and has allowed us to scale up most efficiently.”
CIRO+ and Biomax launched the CIRO+ Data Center, the first integrated patient-centric knowledge management system for patient stratification and targeted therapy in chronic obstructive pulmonary disease in 2012. Based on the BioXM™ Knowledge Management platform, the CIRO+ Data Center helps the organization to better predict patient outcomes and optimize therapy for their patients.
“Biomax is very excited about the medical and economic benefits generated for CIRO+,” says Biomax CEO, Dr. Klaus Heumann. “CIRO+ is proof that investing in knowledge management as a medical backbone is workable and viable both medically and financially. Being the best in delivering the vision of Healthcare 3.0 is our mission. The cooperation with CIRO+ has accomplished this in an outstanding way; it sets the stage for a paradigm shift in complex and chronic disease care that masters the challenges of an aging society without compromising the quality of care for the patient.”
About CIRO+
CIRO+ (Horn, Netherlands), is an international center of excellence for the diagnosis and treatment of people with chronic obstructive pulmonary disease (COPD). To date, CIRO+ is considered the world leader in personalized pulmonary rehabilitation. More information about CIRO+ is available at www.ciro-horn.nl.
Professor Dr. Emiel Wouters, Chairman of the CIRO+ Board of Directors, links these successes to their ongoing collaboration with Biomax, which began five years ago. “Implementing our ambitious, multidisciplinary approach only became possible through the collaboration with Biomax. The Biomax BioXM system has been in routine use at CIRO+ clinics 24/7 for the past two years and has allowed us to scale up most efficiently.”
CIRO+ and Biomax launched the CIRO+ Data Center, the first integrated patient-centric knowledge management system for patient stratification and targeted therapy in chronic obstructive pulmonary disease in 2012. Based on the BioXM™ Knowledge Management platform, the CIRO+ Data Center helps the organization to better predict patient outcomes and optimize therapy for their patients.
“Biomax is very excited about the medical and economic benefits generated for CIRO+,” says Biomax CEO, Dr. Klaus Heumann. “CIRO+ is proof that investing in knowledge management as a medical backbone is workable and viable both medically and financially. Being the best in delivering the vision of Healthcare 3.0 is our mission. The cooperation with CIRO+ has accomplished this in an outstanding way; it sets the stage for a paradigm shift in complex and chronic disease care that masters the challenges of an aging society without compromising the quality of care for the patient.”
About CIRO+
CIRO+ (Horn, Netherlands), is an international center of excellence for the diagnosis and treatment of people with chronic obstructive pulmonary disease (COPD). To date, CIRO+ is considered the world leader in personalized pulmonary rehabilitation. More information about CIRO+ is available at www.ciro-horn.nl.
